MDHearing VoltMax vs Sony CRE-C20
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

MDHearing VoltMax
The MDHearing VoltMax is a behind-the-ear OTC hearing aid priced at $699, earning a B grade with a SoundScore of 3.0/5 in our lab testing. This mid-priced device ranks #62 of 65 in the OTC Hearing Aid category, placing it in the bottom portion of tested products. In our standardized testing, the VoltMax demonstrates excellent feedback handling at 5.0/5, scoring 0.46 points above the category average. This means users are unlikely to experience whistling or squealing during typical wear. However, speech performance presents significant challenges—speech in quiet scores a low 1.9/5 (0.93 points below average), while speech in noise scores 1.0/5 (0.48 points below average). These results suggest limited benefit for understanding conversation in both calm and challenging listening environments. Music streaming is a notable weakness, scoring 0.0/5 and falling 1.92 points below the category average. Users who prioritize streaming audio content from their phones should consider alternatives. Own-voice comfort is mixed at 2.4/5, roughly matching the category average. At this price point, several alternatives offer substantially stronger performance. Devices like the Yeasound RIC800 and Sony CRE-E10 score above 4.5/5 at similar or lower prices. The VoltMax may appeal to users who prioritize feedback-free wear and basic amplification with rechargeable convenience, but those seeking stronger speech clarity should explore higher-performing options in this price range.

Sony CRE-C20
The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Audio scenes
Using MUSHRA scenes (Tuned)
Fitting configuration for tuned fit